About NUCLEOBIO CORP
NucleoBio is a biotechnology company based in San Antonio, TX, developing Prostac, a non-invasive blood test for the early and precise detection of prostate cancer. The test aims to improve diagnostic accuracy and reduce unnecessary treatments.
Early and precise detection of prostate cancer through a non-invasive blood testDetection of prostate cancer in men with elevated PSA scores or symptomsScreening for genetic predisposition to prostate cancerClassification of prostate cancer into risk groups (indolent to aggressive)Assisting physicians in making treatment decisionsTesting for the effectiveness of prostate cancer treatments
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to NUCLEOBIO CORP right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.